fashion -WSS

fashion

author：comprehensive 2025-09-28 02:30:31 - browse：6

Matts Take Column Illustration — Molly Ferguson for STAT

If you’re a drug company executive, you probably feel like you got up on the wrong side of bed.

On Thursday night, President Biden proposed expanding one of his most popular policies: the Medicare price negotiation process that was put in place as part of the Inflation Reduction Act. “Americans pay more for prescription drugs than anywhere else,” Biden said. “It’s wrong and I’m ending it.”

Obviously, the drug industry is not going to be happy about new price limitations in the U.S., the biggest market for pharmaceuticals. But, even more than that, Biden’s move emphasizes a painful reality: That pharmaceutical companies remain one of the biggest political targets in the country — despite their key role in addressing the Covid-19 pandemic and their development of wildly effective new weight loss drugs.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： FDA approval of Sarepta Duchenne genetic therapy gives me hope
Next article： Chinese researcher claims birth of first gene

knowledge

WSS

Mirador, a new biotech startup, launches with $400 million

Surgeons perform first xenotransplant using CRISPR'd pig kidney

Biotech investment managers search for lucrative opportunities

Elevance, SCAN deals highlight health insurer acquisition scrutiny

Ring Therapeutics, a Flagship gene therapy startup, lays off 20% of staff

Flagship Pioneering startup Sonata Therapeutics lays off 21

explore

fashion

focus

Malaria cases in Florida and Texas: Here’s what you need to know

Pfizer, Moderna say biotech, pharma drug development is a sprint

Peter Hotez and the public health issue of online harassment

As AI regulations shape up, health tech startups beg for clarity

At least 13 dead in Texas as scorching temps continue

With Wegovy coverage, Medicare patients may face high costs

Heart attack and stroke risk calculators need revising

Texas board proposes rules on abortion law emergency exemption

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Pregnancy ages women, but effects reverse after delivery

leisure time

Yancopoulos of Regeneron works to expand Dupixent success

Adam's Take: Intra

Bring on the sabbaticals for nurses

Abridge raises $150m as clinical notes automation market heats up

Researchers tackle phage therapy hurdles for wider adoption

Reporting on presidential health from Reagan to Trump and Biden

hotspot

entertainment

knowledge

leisure time